Login / Signup

Metformin treatment results in distinctive skeletal muscle mitochondrial remodeling in rats with different intrinsic aerobic capacities.

Matthew P BubakArik DavidyanColleen L O'ReillySamim A MondalJordan KeastStephen M DoidgeAgnieszka K BorowikMichael E TaylorEvelina VolovičevaMichael T KinterSteven L BrittonLauren Gerard KochMichael B StoutTommy L LewisBenjamin F Miller
Published in: bioRxiv : the preprint server for biology (2024)
The rationale for the use of metformin as a treatment to slow aging was largely based on data collected from metabolically unhealthy individuals. For healthspan extension metformin will also be used in periods of good health. To understand potential context specificity of metformin treatment on skeletal muscle, we used a rat model (HCR/LCR) with a divide in intrinsic aerobic capacity. Outcomes of metformin treatment differed based on baseline intrinsic mitochondrial function, oxidative capacity of the muscle (gastroc vs soleus), and the mitochondrial population (IMF vs SS). Metformin caused lower ADP-stimulated respiration in LCRs, with less of a change in HCRs. However, a washout of metformin resulted in an unexpected doubling of respiratory capacity in HCRs. These improvements in respiratory capacity were accompanied by mitochondrial remodeling that included increases in protein synthesis and changes in morphology. Our findings raise questions about whether the positive findings of metformin treatment are broadly applicable.
Keyphrases
  • skeletal muscle
  • oxidative stress
  • mental health
  • risk assessment
  • machine learning
  • adipose tissue
  • big data
  • social media
  • artificial intelligence